Recently, GRP78 was also implicated in the maintenance/reestablishment of MEK/ERK signaling in therapy-resistant BRAF mutant melanomas, and in maintaining stemness in pancreatic cancer cells in response to therapy-associated oxidative and protein stress [44, 45]. The gene discussed is MAP2K7; the disease is pancreatic neoplasm.